BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 5285069)

  • 1. Role of the lymphocyte in antihemophilic globulin production: a rise in antihemophilic globulin levels in a hemophilic subject with acute lymphoblastic leukemia.
    Bouhasin JD; Monteleone P; Altay C
    J Lab Clin Med; 1971 Jul; 78(1):122-9. PubMed ID: 5285069
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and control of antihemophilic globulin (plasma factor 8).
    Zukoski CF; Hutchin P; Webster WP; Penick G
    Surg Forum; 1970; 21():370-1. PubMed ID: 4936991
    [No Abstract]   [Full Text] [Related]  

  • 3. [Simultaneous occurrence of hemophilia A and acute lymphatic leukemia].
    Schmid L; Schafroth U; Osterwalder B; Senn HJ
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1828-31. PubMed ID: 3122319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin.
    Uszyński L
    Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276
    [No Abstract]   [Full Text] [Related]  

  • 5. [Relationships of factor VIII (antihemophilic globulin) and its weak inhibitors with the spleen. Effect of adrenaline on splenectomized subjects, on splenomegaly and on patients presenting a weak factor VIII inhibitor].
    Mayer G; Kalogjera V; Oberling F; Mayer S; Waitz R
    Haematol Lat; 1971; 13(3):185-206. PubMed ID: 5097059
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-culture synthesis of a factor VIII-like activity.
    Zacharski LR; Bowie EJ; Titus JL; Owen CA
    Mayo Clin Proc; 1969 Nov; 44(11):784-92. PubMed ID: 4981692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative determination of antihemophilic globulin (Factor VIII)].
    Lisichkov T
    Vutr Boles; 1972; 11(4):62-7. PubMed ID: 4680004
    [No Abstract]   [Full Text] [Related]  

  • 10. [The dosage of antihemophilic globulin, or antihemophilic plasma as well as Cohn's fraction I in factor VIII deficiency].
    Hrubisková K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):363-8. PubMed ID: 4195283
    [No Abstract]   [Full Text] [Related]  

  • 11. Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia.
    Norman JC; Lambilliotte JP; Kojima Y; Sise HS
    Science; 1967 Nov; 158(3804):1060-1. PubMed ID: 6058346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of factor 8 (antihemophilic factor).
    Hershgold EJ
    Prog Hemost Thromb; 1974; 2(0):99-139. PubMed ID: 4137137
    [No Abstract]   [Full Text] [Related]  

  • 13. [The blood coagulation system in acute childhood lymphoid leukemia].
    Goldschmidt B; Koós R
    Orv Hetil; 1980 Oct; 121(43):2635-7. PubMed ID: 6937855
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of erythrophosphatide in the determination of antihemophilic globulin activity].
    Rakitianskaia AA; Tsvirko DG; Gilevskiĭ EN
    Lab Delo; 1983; (6):22-4. PubMed ID: 6193315
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pseudohemophilia due to antihemophilic globulin inhibitor (factor VIII)].
    Procházka J; Podivínský R; Kouril F; Hadam I; Velemínský J
    Vnitr Lek; 1970 Nov; 16(11):1091-103. PubMed ID: 5488288
    [No Abstract]   [Full Text] [Related]  

  • 16. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihemophilic factor-nineteen months' experence in its production and use.
    Oka WT; Glueck HI; Mauer AM; Hoxworth PI
    Am J Med Technol; 1968 Jul; 34(7):373-87. PubMed ID: 5672102
    [No Abstract]   [Full Text] [Related]  

  • 18. Sustained factor VIII production in hemophiliac mice 1 year after engraftment with induced pluripotent stem cell-derived factor VIII producing endothelial cells.
    Alipio Z; Adcock DM; Waner M; O TM; Fink LM; Ward DC; Ma Y
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):502-4. PubMed ID: 20595826
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prothrombin level in hemophilic blood after the addition in vitro of Cohn's fraction Ia (antihemophilic globulin)].
    TROPEANO L
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1892-4. PubMed ID: 13059109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Factor VIII complexes in acute lymphoblastic leukemia in childhood].
    Goldschmidt B; Koós R
    Orv Hetil; 1986 Jan; 127(3):131-4. PubMed ID: 3080721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.